Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Parenterally administered ascorbic acid modulates sepsis-induced inflammation and coagulation in experimental animal models. The objective of this randomized, double-blind, placebo-controlled, phase I trial wa...
Citation: Journal of Translational Medicine 2014 12:32